Cancer Treatment Immune Cells Antibody Product Candidate Dostarlimab CAR-T Therapy Tumor Shrinkage CAR-T Cell Therapy Patient Experiences Immunosuppressants Eczema Treatments
Oncolytic HSV-1 with nivolumab triggered tumor shrinkage or disappearance throughout the body in patients who had not responded to existing immunotherapies.